These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22915814)

  • 1. Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections.
    Zhao J; Wohlford-Lenane C; Zhao J; Fleming E; Lane TE; McCray PB; Perlman S
    J Virol; 2012 Nov; 86(21):11416-24. PubMed ID: 22915814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol
    Kumaki Y; Salazar AM; Wandersee MK; Barnard DL
    Antiviral Res; 2017 Mar; 139():1-12. PubMed ID: 27956136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
    Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
    J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.
    Fett C; DeDiego ML; Regla-Nava JA; Enjuanes L; Perlman S
    J Virol; 2013 Jun; 87(12):6551-9. PubMed ID: 23576515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB/c mice.
    Kumaki Y; Day CW; Bailey KW; Wandersee MK; Wong MH; Madsen JR; Madsen JS; Nelson NM; Hoopes JD; Woolcott JD; McLean TZ; Blatt LM; Salazar AM; Smee DF; Barnard DL
    Antivir Chem Chemother; 2010 Mar; 20(4):169-77. PubMed ID: 20231782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice.
    Roberts A; Deming D; Paddock CD; Cheng A; Yount B; Vogel L; Herman BD; Sheahan T; Heise M; Genrich GL; Zaki SR; Baric R; Subbarao K
    PLoS Pathog; 2007 Jan; 3(1):e5. PubMed ID: 17222058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
    Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
    J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
    Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
    J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
    Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N
    J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
    Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.
    Liu YV; Massare MJ; Barnard DL; Kort T; Nathan M; Wang L; Smith G
    Vaccine; 2011 Sep; 29(38):6606-13. PubMed ID: 21762752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.
    Sheahan T; Morrison TE; Funkhouser W; Uematsu S; Akira S; Baric RS; Heise MT
    PLoS Pathog; 2008 Dec; 4(12):e1000240. PubMed ID: 19079579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly I:C adjuvanted inactivated swine influenza vaccine induces heterologous protective immunity in pigs.
    Thomas M; Wang Z; Sreenivasan CC; Hause BM; Gourapura J Renukaradhya ; Li F; Francis DH; Kaushik RS; Khatri M
    Vaccine; 2015 Jan; 33(4):542-8. PubMed ID: 25437101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.
    Sheahan T; Whitmore A; Long K; Ferris M; Rockx B; Funkhouser W; Donaldson E; Gralinski L; Collier M; Heise M; Davis N; Johnston R; Baric RS
    J Virol; 2011 Jan; 85(1):217-30. PubMed ID: 20980507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consecutive inoculations of influenza virus vaccine and poly(I:C) protects mice against homologous and heterologous virus challenge.
    Moriyama M; Chino S; Ichinohe T
    Vaccine; 2017 Feb; 35(7):1001-1007. PubMed ID: 28111142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal delivery of Duox2 DNA using cationic polymer can prevent acute influenza A viral infection in vivo lung.
    Kim BJ; Cho SW; Jeon YJ; An S; Jo A; Lim JH; Kim DY; Won TB; Han DH; Rhee CS; Kim HJ
    Appl Microbiol Biotechnol; 2018 Jan; 102(1):105-115. PubMed ID: 28936773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhinovirus Reduces the Severity of Subsequent Respiratory Viral Infections by Interferon-Dependent and -Independent Mechanisms.
    Van Leuven JT; Gonzalez AJ; Ijezie EC; Wixom AQ; Clary JL; Naranjo MN; Ridenhour BJ; Miller CR; Miura TA
    mSphere; 2021 Jun; 6(3):e0047921. PubMed ID: 34160242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Superiority of IFN-λ as a Therapeutic Candidate to Control Acute Influenza Viral Lung Infection.
    Kim S; Kim MJ; Kim CH; Kang JW; Shin HK; Kim DY; Won TB; Han DH; Rhee CS; Yoon JH; Kim HJ
    Am J Respir Cell Mol Biol; 2017 Feb; 56(2):202-212. PubMed ID: 27632156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.
    Lee W; Kingstad-Bakke B; Kedl RM; Kawaoka Y; Suresh M
    J Virol; 2021 Jul; 95(15):e0053021. PubMed ID: 33952647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.